Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 7 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 10407484

    Compositions and methods for modulating T-cell mediated immune response

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  2. US 10383939

    Light-activated compositions and methods using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  3. US 10363288

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  4. US 10350265

    Therapeutic applications of Smad7

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  5. US 10329338

    Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

    The Regents of the University of Colorado · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  6. US 10307437

    Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  7. US 10300107

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2019 · Expires May 23, 2039

    granted

  8. US 10280415

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted

  9. US 10278986

    Antibody-siRNA conjugates and uses therefor

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted

  10. US 10265387

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  11. US 10258606

    Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  12. US 10259846

    Bouvardin derivatives and therapeutic uses thereof

    The Regents of the University of Colorado · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  13. US 10253024

    Polycyclic indoline and indolenine compounds

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  14. US 10251955

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  15. US 10233222

    Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  16. US 10233235

    Modulating the alternative complement pathway

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  17. US 10232035

    Conditionally replication deficient herpes virus and use thereof in vaccines

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  18. US 10221226

    LEDGF peptides and formulations thereof for treatment of degenerative disorders

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  19. US 10221222

    Dermaseptin-type and piscidin-type antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  20. US 10214487

    Indole derivatives and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  21. US 10202397

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  22. US 10189952

    Degradable thiol-ene polymers

    The Regents of the University of Colorado, a body · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  23. US 10160962

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  24. US 10155020

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.